Although metal-on-metal hip implants are still on the market, despite their well-documented problems, their use is declining, according to a Chicago Tribune story.
A Chicago Tribune report on the devices mentions a survey taken by the American Academy of Orthopaedic Surgeons in 2010, which showed 16 percent of surgeons were using metal-on-metal implants before the U.S. Food and Drug Administration warned ...
continue reading...
Johnson & Johnson’s Synthes unit, a maker of tools and implants to treat damaged bones, has been sued by the family of a woman who died during an unapproved trial of a bone cement, Bloomberg reports.
It’s an ironic development for Johnson & Johnson, which recently purchased Synthes for $19.7 billion, largely in the hopes it would help offset revenue losses related to a series of recalls and legal problems over ...
continue reading...
A state appeals court has upheld the dismissal of Pennsylvania’s lawsuit against Johnson & Johnson over allegations that the company improperly marketed its antipsychotic drug Risperdal, the Wall Street Journal reports.
Pennsylvania prosecutors had filed suit against J&J in 2007, trying to recover expenses incurred by the state’s Medicaid program for reimbursing pharmacies over the purchase of Risperdal. Prosecutors alleged that J&J had promoted Risperdal for unapproved – or “off-label” – ...
continue reading...
According to a report in U.S. News and World Report, people who have total hip or knee replacement surgery are about 30 times more likely to have a heart attack in the two weeks after the procedure.
Researchers in the Netherlands published the results of their findings in a study published in the Archives of Internal Medicine.
The report quotes lead researcher Dr. Arief Lalmohamed of Utrecht University in the Netherlands as ...
continue reading...Johnson & Johnson has set aside $3 billion to deal with the legal fallout from 93,000 all-metal hip implants recalled in 2010, according to a story in the Chicago Tribune. But the healthcare giant may face even more expenses down the line from more problems with a new line of hip implants.
The company’s DePuy Orthopaedics division is facing 3,000 lawsuits filed over the recalled model. And a subsequent model that ...
continue reading...The Wall Street Journal reports that Johnson & Johnson and federal prosecutors have reached a settlement over allegations that the company illegally marketed its antipsychotic drug Risperdal and other medications.
That settlement will reportedly be about $2.2 billion, and include about $400 million in criminal fines.
But the settlement won’t be the end of Johnson & Johnson’s legal troubles. It’s still facing thousands of lawsuits from plaintiffs alleging that the company’sread more.... --> continue reading...
